Full-Time

Associate Director

Business Data Science

Confirmed live in the last 24 hours

Takeda

Takeda

10,001+ employees

Develops and commercializes biopharmaceuticals and vaccines

Compensation Overview

$149.1k - $234.3k/yr

+ Short-term Incentives + Long-term Incentives

Expert

Highland Park, IL, USA

This position is classified as 'hybrid' in accordance with Takeda’s Hybrid and Remote Work policy.

Category
Data Science
Data Analysis
Data & Analytics
Required Skills
Data Science
Machine Learning
Data Analysis
Requirements
  • Ph.D. or master’s degree in any area of social science, statistics, management science, engineering, computer science, or a closely related field; or an undergraduate degree in one of these areas plus relevant work experience.
  • Experience with data analytics from end-to-end, i.e., including ideation, proposal creation, getting stakeholder buy-in, designing analytics models/solutions, building prototypes, and working with IT/Data Science teams to deploy and scale solutions.
  • 10+ years of experience in advanced analytics and modeling in the areas of business performance analysis, forecasting, pricing, optimization, and/or consumer behavior.
  • Excellent verbal and written communication and presentation skills. Able to communicate effectively to all levels of the organization, including senior leadership.
  • Bring a growth mindset, curiosity, positivity, intuitive thinking, and a passion for excellence.
Responsibilities
  • Hands-on involvement in the execution of FPA models, analyzing outputs, explaining and communicating results, and conducting rapid follow-on analyses.
  • Work closely across the business in a consultative and cross-functional capacity to identify and propose ways to improve our use of data.
  • Work across the FPA team to continuously improve process, documentation, and knowledge management.
  • Improve measurement of business performance through focus on the right metrics, improving metric accuracy, and proposing & creating statistical models to better understand complex dynamics.
  • Identify and help implement best practices, create and maintain documentation, improve process, and advance knowledge management across the Forecasting, Pricing, and Analytics (FPA) team.
  • Drive continuous improvement initiatives to achieve cost savings and efficiency gains.
  • Work with partners, vendors, and consultants on cross-functional projects, which can include developing solution functional requirements, feature prioritization, and aspects of data management/governance.
  • Hands-on model execution, output management, and communicating results clearly and succinctly.
  • Partner with the Data, Digital, and Technology (DD&T) Data Science team and consultants to develop and improve on existing analytical models.
  • Complete ad hoc analytics analyses, which can include descriptive analyses and/or predictive modeling.
  • Build AI/ML and statistical model prototypes for measuring and understanding key drivers of our business.
  • Build strong relationships with cross-functional partners for efficient alignment, coordination, and information sharing across teams.
Desired Qualifications
  • Healthcare or Plasma Industry related experience a plus.
  • Management consulting experience a plus.

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines. The company invests heavily in research and development to create new molecular entities (NMEs) and has a pipeline aiming for multiple product launches in the coming years. Takeda's products are designed to meet the needs of healthcare providers, hospitals, and patients around the world. What sets Takeda apart from its competitors is its strong commitment to patient-centric values and environmental sustainability, recognizing the connection between human health and environmental health. The company's goal is to innovate and provide life-changing therapies while ensuring that patient needs are prioritized.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Takeda's collaboration with BridGene could enhance its immunology and neurology offerings.
  • The SEA AtM Summit highlights Takeda's commitment to expanding access to medicines in Asia.
  • Positive Phase III trial results for a cancer drug strengthen Takeda's oncology portfolio.

What critics are saying

  • Antitrust litigation in the US could impact Takeda's market position and reputation.
  • The $770 million deal with BridGene poses financial risks if outcomes aren't met.
  • Geopolitical risks could disrupt Takeda's global operations and supply chain.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company emphasizes patient-centric values in its operations and innovations.
  • Takeda's robust pipeline includes 11 NMEs with plans for 15 launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

MLex
Mar 4th, 2025
Meijer seeks quick appeal in US antitrust case against Takeda

( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.

BioSpace
Mar 3rd, 2025
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial

Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.

Access Health
Mar 3rd, 2025
Strengthening Access to Medicines in Southeast Asia: Highlights from Southeast Asia Access to Medicine (SEA AtM) Summit

ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.

Pharmaceutical Technology
Feb 25th, 2025
Takeda broadens its deal with BridGene for up to $770m

Bridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology.

Nyasa Times
Feb 6th, 2025
Forgotten Children: Mzimba's Tukuyu CBCC Struggles to Provide Basic Education

VillageReach, in partnership with Takeda Pharmaceutical Company Limited, has launched a new initiative aimed at strengthening health systems and improving...